Fulminant demyelinating encephalomyelitis: Insights from antibody studies and neuropathology
about
Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): Extending the spectrum of MOG antibody positive diseasesAutoantibodies to MOG in a distinct subgroup of adult multiple sclerosisMyelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases.Influence of type I IFN signaling on anti-MOG antibody-mediated demyelination.Autoimmunity: The good, the bad, and the uglyNeuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatusMOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients.MOG antibody-related disorders: common features and uncommon presentations.ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reports.Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination.Biomarkers in the evolution of multiple sclerosis.Differences in the Reponses to Apheresis Therapy of Patients With 3 Histopathologically Classified Immunopathological Patterns of Multiple Sclerosis.Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration.Defining distinct features of anti-MOG antibody associated central nervous system demyelination.MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder.Differences in clinical features between optic neuritis in neuromyelitis optica spectrum disorders and in multiple sclerosis
P2860
Q28273255-E9BDD76D-3B86-4E83-A587-4B9E16CA9D24Q29036090-1E75E96B-8BBE-401B-963D-58532B729E4BQ33645795-1633C0A3-B2B7-4602-8344-C190D952FE45Q33831179-498655FC-C969-48A7-BAC6-4B213536D9D5Q36359919-702B38B4-73A5-4429-B27A-B92EA82675A8Q36827205-BF834B49-A3C1-449E-968D-C41A7F8396CBQ37374434-22A10237-8565-4078-B496-2B2031CD935BQ37383474-FCC06277-947C-4B67-A0D6-5D02413FEA97Q38645211-B467C2EB-8C13-450B-99AA-19E6ABA3351DQ41877972-B7ACD023-0BBD-4136-86C4-8CC43A2064EBQ42627948-03636611-CEDB-4984-84AC-B4C4C504F4B6Q47578484-A682D443-DF47-49FB-8713-F4E14A022E5FQ50194965-15325FFE-728D-4603-A252-D0BF09B00500Q51327401-8BD7521F-DA9E-4BEC-A436-4106F2C1DB4EQ52603606-DAE5A7AA-31C1-4E7E-AECE-CA60AF960220Q55221002-3D96C3DF-9C8B-4265-88F3-1EDF221FAB1CQ58788487-1E1CE174-8CC2-43BC-BD2F-D103FBE98758
P2860
Fulminant demyelinating encephalomyelitis: Insights from antibody studies and neuropathology
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Fulminant demyelinating enceph ...... ody studies and neuropathology
@en
Fulminant demyelinating enceph ...... ody studies and neuropathology
@nl
type
label
Fulminant demyelinating enceph ...... ody studies and neuropathology
@en
Fulminant demyelinating enceph ...... ody studies and neuropathology
@nl
prefLabel
Fulminant demyelinating enceph ...... ody studies and neuropathology
@en
Fulminant demyelinating enceph ...... ody studies and neuropathology
@nl
P2093
P2860
P50
P3181
P1476
Fulminant demyelinating enceph ...... ody studies and neuropathology
@en
P2093
Erich Schmutzhard
Franziska Di Pauli
Kathrin Schanda
Kazuo Fujihara
Paul Rhomberg
Romana Höftberger
Ronny Beer
Thomas Berger
P2860
P3181
P356
10.1212/NXI.0000000000000175
P407
P577
2015-11-04T00:00:00Z